NCT03055351 is a NA clinical trial of Stop&Go Intervention in Substance Use Disorder, sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.

Who is sponsoring NCT03055351?

NCT03055351 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.

What drugs are being tested in NCT03055351?

Interventions in NCT03055351: Stop&Go Intervention.

What condition does NCT03055351 study?

NCT03055351 studies Substance Use Disorder, Motivation.

Is NCT03055351 still recruiting?

NCT03055351 is currently completed. Last updated 1 March 2019.

Last reviewed 2019-03-01 · How we verify

NCT03055351

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stop&Go: an Intervention Program to Promote Healthy and Active Lifestyles Among Patients With Substance Use Disorders

Completed NA Last updated 1 March 2019

What this trial tests

NA trial testing Stop&Go Intervention in Substance Use Disorder in 100 participants. Completed in 30 November 2018.

Timeline

17 February 2017

Primary endpoint
30 November 2018

30 November 2018

Quick facts

Lead sponsor	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	100
Start date	17 February 2017
Primary completion	30 November 2018
Estimated completion	30 November 2018
Sites	1 location across Spain

Drugs / interventions tested

Stop&Go Intervention

Conditions studied

Substance Use Disorder — all drugs for Substance Use Disorder →
Motivation — all drugs for Motivation →

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Who can join

18 and older, any sex, with Substance Use Disorder or Motivation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stop\&Go is an intervention program aimed at promoting a healthy and physically active lifestyle for patients requiring inpatient detoxification treatment. The program includes two different phases. Phase I is aimed at understanding the variables related with adherence to healthy lifestyle interventions. Phase II will use the knowledge obtained in Phase I to develop and evaluate an intervention based on Self-determination theory to promote healthy and physically active lifestyles for patients admitted to an inpatient detoxification centre. The Stop\&Go intervention is hypothesized to help patients move towards a healthy lifestyle and thus, may bring about changes in patients' (1) knowledge acquired, (2) indicators of healthy habits (e.g., exercise motivation) and (3) psychological well-being and ill-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Substance Use Disorder

Currently open trials in the same condition.

NCT07168642 — A Type I Hybrid Effectiveness-Implementation Trial of MIO · NA · recruiting
NCT06580457 — Personalized Approach to Healthy Use and Recovery (PATH) Trial · NA · recruiting
NCT07010016 — Neuromodulation in Substance Use Disorders · NA · active not recruiting
NCT06432985 — Smoking Cessation CM for Veterans With or at Risk for Cancer · NA · recruiting
NCT06552741 — Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP · recruiting

Other Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials

Trials by the same sponsor.

NCT07343882 — Quantification of Systemic Congestion by Ultrasound As a Predictor of Weaning Failure From Mechanical Ventilation · NA · not yet recruiting
NCT07530237 — Efficacy of Periarticular Vasoconstrictor Infiltration (PVI) in Reducing Bleeding and Postoperative Pain in Lumbar Fusio · active not recruiting
NCT07369310 — Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming · NA · not yet recruiting
NCT07314190 — Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodege · enrolling by invitation
NCT07239843 — Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychia · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03055351 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Last refreshed: 1 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03055351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing